Regression of skeletal manifestations of hyperparathyroidism with oral vitamin D

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 7, 2006, Pages 2480-2483

  Arabi, Asma ^a   Khoury, Nabil ^a   Zahed, Laila ^a   Birbari, Adel ^a   Fuleihan, Ghada El Hajj ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; CREATININE; PARATHYROID HORMONE; RESTRICTION ENDONUCLEASE; VITAMIN D; VITAMIN D RECEPTOR;

ADULT; ALBRIGHT SYNDROME; ANAMNESIS; BONE DENSITY; BONE DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DUAL ENERGY X RAY ABSORPTIOMETRY; FOREARM; GENOTYPE; HIP; HUMAN; KIDNEY FAILURE; LABORATORY TEST; MALE; OSTEOLYSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REMISSION; RIB; SECONDARY HYPERPARATHYROIDISM; THORACIC SPINE; THORAX RADIOGRAPHY; ULTRASOUND;

BONE DENSITY; BONE DISEASES; CALCIUM; CHOLECALCIFEROL; GENOTYPE; HUMANS; HYDROXYCHOLECALCIFEROLS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OSTEITIS FIBROSA CYSTICA; OSTEOPOROSIS; RECEPTORS, CALCITRIOL; THALASSEMIA; TOMOGRAPHY, X-RAY COMPUTED; VITAMIN D;

EID: 33745766895     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2518     Document Type: Conference Paper

References (23)

1. Bilezikian JP, Silverberg J 2000 Clinical spectrum of primary hyperparathyroidism. Rev Endocr Metab Disord 1:237-245
2. Khan A, Bilezekian JP 2000 Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ 163:184-187
3. Raeburn C, Cothren C, McIntyre R 2002 End-stage skeletal manifestations of severe hyperparathyroidism. Surgery 131:896-898
4. Nordenstrom E, Westerdahl J, Bergenfelz A 2004 Recovery of bone mineral density in 121 patients after surgery for primary hyperparathyroidism. World J Surg 28:502-507
5. Kulak C, Bandeira C, Voss D, Sobieszczyk S, Silverberg S, Bandeira F, Bilezikian JP 1998 Marked improvement in bone mass after parathyroidectomy in osteitis fibrosa cystica. J Clin Endocrinol Metab 83:732-735
6. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA 1994 Prediction of bone density from vitamin D receptor alleles. Nature 367:284-285
7. Agarwal G, Mishra S, Kar D, Singh A, Arya V, Gupta S, Mithal A 2002 Recovery pattern of patients with osteitis fibrosa cystica in primary hyperparathyroidism after successful parathyroidectomy. Surgery 132:1075-1085
8. Franco M, Bendini J, Albano D, Barillon D, Cassuto E, Bracco J 2002 Radiographic follow-up of a phalangeal Brown tumor. Joint Bone Spine 69:506-510
9. Lumb GA, Stanbury SW 1974 Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism. Am J Med 56:833-839
10. Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ 1989 Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321:274-279
11. Mourad G, Argiles A, Lorho R, Flavier JL, Canaud B, Mion M 1995 Control of severe hyperparathyroidism and regression of Brown tumor after treatment with i.v. alfacalcidol in a uremic patient. Nephrol Dial Transplant 10:552-554
12. Rodriguez M, Felsenfeld AJ, Williams C, Pederson JA, Liach F 1991 The effect of long term intravenous calcitriol administration on parathyroid function in hemodialysis patient. J Am Soc Nephrol 2:1014-1020
13. Brandi L, Daugaard H, Tvedegaard E, Storm T, Olgaard K 1989 Effect of intravenous 1-α-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis. Nephron 53:194-200
14. Fajtova VT, Sayegh MH, Hickey N, Aliabadi P, Lazarus JM, LeBoff MS 1995 Intact parathyroid hormone levels in renal insufficiency. Calcif Tissue Int 57:329-335
15. Levy A, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, Zeuw D, Hostetter TH, Lameire N, Eknoyan G 2005 Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 67:2089-2100
16. Dent CE 1962 Some problems of hyperparathyroidism. BMJ 5317:1419-1425
17. Carling T, Ridefelt P, Hellman P, Juhlin C, Lundgren E, Akerstrom G, Rastad J 1998 Vitamin D receptor gene polymorphism and parathyroid calcium sensor protein (CAS/gp330) expression in primary hyperparathyroidism. World J Surg 22:700-707
18. Yokohama K, Shigematsu T, Tsukada T, Ogura Y, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosaya T 1998 ApaI polymorphism in the vitamin D receptor gene may affect the parathyroid response in Japanese with endstage renal disease. Kidney Int 53:454-458
19. Vigo Gago E, Cadarso-Suarez C, Perez-Fernandez R, Romero Burgos R, Devesa Mugica J, Segura Iglesias C 2005 Association between vitamin D receptor FokI. Polymorphism and serum parathyroid hormone level in patients with chronic renal failure. J Endocrinol Invest 28:117-121
20. Alvarez-Hernandez D, Naves M, Santamaria I, Menarguez J, Torregrosa V, Cannata J 2003 Response of parathyroid glands to calcitriol in culture: is this response mediated by the genetic polymorphisms in vitamin D receptors? Kidney Int 85:S19-S22
21. Marco MP, Martinez I, Betriu A, Craver L, Fibla MJ, Fernandez E 2001 Influence of Bsml vitamin D receptor gene polymorphism on the response to a single bolus of calcitriol in hemodialysis patients. Clin Nephrol 56:111-116
22. Carling T, Ridefelt P, Hellman P, Juhlin C, Rastad J, Akerstrom G 1997 vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism. J Clin Endocrinol Metab 82:1772-1775
23. Stanbury SW 1977 The role of vitamin D in renal bone disease. Clin Endocrinol (Oxf) 7(Suppl):25S-30S